Status:
TERMINATED
Study Evaluating of Calcineurin Inhibitors Versus Sirolimus in Renal Allograft Recipient
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Conditions:
Kidney Transplantation
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
This study will evaluate whether conversion from cyclosporine, a calcineurin inhibitor (CI) to sirolimus (SRL) results in improved long-term renal function without a negative impact on safety or immun...
Detailed Description
This open-label, randomized, parallel-group, comparative, outpatient study will be conducted in multiple centers in Taiwan. The study will randomize approximately 120 patients. 80 patients will be ra...
Eligibility Criteria
Inclusion
- Subjects must be at least 18 years of age.
- Subjects who are 6 to 60 months after renal transplantation.
- Subjects who have a stable graft function.
Exclusion
- Subjects with active major infection, including HIV, decreased platelets, elevated lipids, or multiple organ transplants.
Key Trial Info
Start Date :
April 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2008
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT00452361
Start Date
April 1 2007
End Date
August 1 2008
Last Update
September 3 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Select Cities, Taiwan